A Review: Advancements in Nanomedicine: The Role of Smart Polymers in Chronic Disease Management
DOI:
https://doi.org/10.53851/psijk.v2.i8.35-40Keywords:
Smart polymers, nanomedicine, drug delivery, cancer therapy, pulmonary diseases, stimuli-responsive materials, nanocarriersAbstract
Smart polymers have emerged as pivotal tools in the advancement of modern nanomedicine due to their stimuli-responsive behavior, biocompatibility, and functional versatility. These materials can intelligently respond to internal and external cues such as pH, temperature, enzymes, and oxidative stress, making them ideal candidates for targeted drug delivery and diagnostic applications. This review explores the mechanisms and classifications of smart polymers, highlighting their roles in cancer therapy and chronic pulmonary diseases. Particular emphasis is placed on their integration into nanocarriers, hydrogels, and responsive implants to overcome physiological barriers and enhance therapeutic efficacy. Furthermore, current clinical trials and preclinical studies are discussed to assess their translational potential. Despite significant progress, challenges related to biocompatibility, tumor penetration, and large-scale manufacturing remain. Future directions suggest the integration of artificial intelligence, personalized medicine, and biosensor technology to accelerate smart polymer innovation. This comprehensive overview underscores the transformative potential of smart polymers in redefining personalized and precision healthcare.

